2023
A unique case of Bloom syndrome with a combination of genetic hits: A lesson from trio-based exome sequencing: A case report
WAYHELOVÁ, Markéta; Vladimíra VALLOVÁ; Petr BROŽ; Aneta MIKULÁŠOVÁ; Dominika MACHÁČKOVÁ et al.Základní údaje
Originální název
A unique case of Bloom syndrome with a combination of genetic hits: A lesson from trio-based exome sequencing: A case report
Autoři
WAYHELOVÁ, Markéta; Vladimíra VALLOVÁ; Petr BROŽ; Aneta MIKULÁŠOVÁ; Dominika MACHÁČKOVÁ; Hana Dynková FILKOVÁ; Jan SMETANA; Alena TAKÁCSOVÁ; Renata GAILLYOVÁ a Petr KUGLÍK
Vydání
Molecular Medicine Reports, Spandidos Publications, 2023, 1791-2997
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10603 Genetics and heredity
Stát vydavatele
Řecko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.400
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14310/23:00134634
Organizační jednotka
Přírodovědecká fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
exome sequencing; BLM gene; Bloom syndrome; cancer-predisposing syndrome; copy-number neutral loss of heterozygosity
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 23. 5. 2023 12:39, Mgr. Marie Novosadová Šípková, DiS.
Anotace
V originále
Pathogenic variants affecting the BLM gene are responsible for the manifestation of extremely rare cancer‑predisposing Bloom syndrome. The present study reports on a case of an infant with a congenital hypotrophy, short stature and abnormal facial appearance. Initially she was examined using a routine molecular diagnostic algorithm, including the cytogenetic analysis of her karyotype, microarray analysis and methylation‑specific MLPA, however, she remained undiagnosed on a molecular level. Therefore, she and her parents were enrolled in the project of trio‑based exome sequencing (ES) using Human Core Exome kit. She was revealed as a carrier of an extremely rare combination of causative sequence variants altering the BLM gene (NM_000057.4), c.1642C>T and c.2207_2212delinsTAGATTC in the compound heterozygosity, resulting in a diagnosis of Bloom syndrome. Simultaneously, a mosaic loss of heterozygosity of chromosome 11p was detected and then confirmed as a borderline imprinting center 1 hypermethylation on chromosome 11p15. The diagnosis of Bloom syndrome and mosaic copy‑number neutral loss of heterozygosity of chromosome 11p increases a lifetime risk to develop any types of malignancy. This case demonstrates the trio‑based ES as a complex approach for the molecular diagnostics of rare pediatric diseases.
Návaznosti
| NU20-07-00145, projekt VaV |
|